Bruker Corporation cash flow to debt ratio of 6.56% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.

Bruker Corporation's free cash flow has decreased 89.78% from $136.00M last year to $13.90M, signaling decreasing performance

Bruker Corporation's debt to equity ratio is 0.80, which means that the company's assets are unhealthy financed, signaling financial risk.

Bruker Corporation's debt has decreased relative to shareholder equity from 1.26 last year to 0.80 today, signaling strengthened financials

Bruker Corporation has a net debt to EBITDA ratio of 5.76x, which exceeds the 3.00x threshold, indicating high leverage and potential financial risk

Bruker Corporation's interest coverage ratio of 2.89 indicates that earnings with margin can cover interest payments on company debt

Bruker Corporation's profit margin has decreased (160.56%) in the last year from 3.36% to -2.03%, signaling decreasing performance

Bruker Corporation's short-term assets of $2.21B exceed its short-term liabilities of $1.28B

Bruker Corporation's return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization

Bruker Corporation's return on equity of -2.92%, is lower than 15.00%, indicating bad performance

Bruker Corporation's operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation

Bruker Corporation had positive net income in 4 out of 5 years, indicating stable and consistent earnings

Bruker Corporation has positive free cash flow, indicating the company generates cash after capital expenditures

Bruker Corporation has a free cash flow yield of 0.16%, which is below the 2.00% threshold, indicating limited cash return relative to market value

Bruker Corporation's yearly earnings has decreased 107.60% since last year from $113.10M to $-8.60M, signaling decreasing performance

Bruker Corporation's yearly revenue has increased 2.08% since last year from $3.37B to $3.44B, signaling increasing performance

ROIC 2.56% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.

Bruker Corporation's 3-year revenue CAGR of 10.74% is positive, indicating growing revenue over the past 3 years

Bruker Corporation had revenue growth in 5 out of 5 years, indicating consistent revenue performance

Bruker Corporation had positive ROE in 4 out of 5 years, indicating consistent and reliable returns on equity

Bruker Corporation has insufficient data to evaluate this check.

Bruker Corporation has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Bruker Corporation is overvalued relative to its fair value price of 1.77 based on EBITDA multiple model

Bruker Corporation has an EV/EBITDA ratio of 34.10x, which exceeds the 20.00x threshold, indicating the stock may be overvalued relative to its operating earnings

Bruker Corporation is undervalued relative to its fair value price of 59.72 based on Earnings Fair Value model

Bruker Corporation has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Bruker Corporation has a price-to-book ratio of 3.54x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value

Bruker Corporation has a price-to-sales ratio of 2.45x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue